Sha J - Search Results

1

Qian H, Chi C, Tricard T, Zhu Y, Dong L, Wang Y, Sha J, Wang J, Ma Z, Wang Y, Liu J, Dong B, Pan J, Xue W. Qian H, et al. Among authors: sha j. J Urol. 2024 May;211(5):657. doi: 10.1097/JU.0000000000003921. Epub 2024 May 1. J Urol. 2024. PMID: 38591698 No abstract available.

2

A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

Qian H, Chi C, Tricard T, Zhu Y, Dong L, Wang Y, Sha J, Wang J, Ma Z, Wang Y, Liu J, Dong B, Pan J, Xue W. Qian H, et al. Among authors: sha j. J Urol. 2024 May;211(5):648-655. doi: 10.1097/JU.0000000000003876. Epub 2024 Apr 9. J Urol. 2024. PMID: 38591703 Clinical Trial.

3

Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.

Fan L, Fei X, Zhu Y, Pan J, Sha J, Chi C, Gong Y, Du X, Zhou L, Dong B, Xue W. Fan L, et al. Among authors: sha j. J Urol. 2021 Feb;205(2):461-469. doi: 10.1097/JU.0000000000001363. Epub 2020 Sep 8. J Urol. 2021. PMID: 32897803

4

Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination.

Fan L, Fei X, Zhu Y, Chi C, Pan J, Sha J, Xin Z, Gong Y, Du X, Wang Y, Dong B, Xue W. Fan L, et al. Among authors: sha j. J Urol. 2021 Sep;206(3):630-637. doi: 10.1097/JU.0000000000001819. Epub 2021 Apr 27. J Urol. 2021. PMID: 33904759

5

Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors.

Fan L, Dong B, Chi C, Wang Y, Gong Y, Sha J, Pan J, Shangguan X, Huang Y, Zhou L, Xue W. Fan L, et al. Among authors: sha j. BMC Urol. 2018 Dec 3;18(1):110. doi: 10.1186/s12894-018-0416-6. BMC Urol. 2018. PMID: 30509237 Free PMC article.

6

Prostate cancer treatment - China's perspective.

Liu J, Dong L, Zhu Y, Dong B, Sha J, Zhu HH, Pan J, Xue W. Liu J, et al. Among authors: sha j. Cancer Lett. 2022 Dec 1;550:215927. doi: 10.1016/j.canlet.2022.215927. Epub 2022 Sep 24. Cancer Lett. 2022. PMID: 36162714 Review.

7

Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations.

Chi C, Liu J, Fan L, Zhu Y, Wang Y, Sha J, Huang Y, Dong B, Pan J, Xue W. Chi C, et al. Among authors: sha j. Ther Adv Med Oncol. 2022 Sep 30;14:17588359221128356. doi: 10.1177/17588359221128356. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36199621 Free PMC article.

8

PRKAR2B promotes prostate cancer metastasis by activating Wnt/β-catenin and inducing epithelial-mesenchymal transition.

Sha J, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W. Sha J, et al. J Cell Biochem. 2018 Sep;119(9):7319-7327. doi: 10.1002/jcb.27030. Epub 2018 May 15. J Cell Biochem. 2018. PMID: 29761841

9

Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.

Pan J, Chi C, Qian H, Zhu Y, Shao X, Sha J, Xu F, Wang Y, Karnes RJ, Dong B, Xue W. Pan J, et al. Among authors: sha j. Urol Oncol. 2019 Dec;37(12):991-998. doi: 10.1016/j.urolonc.2019.07.009. Epub 2019 Aug 27. Urol Oncol. 2019. PMID: 31466813

10

Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.

Sha J, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W. Sha J, et al. J Cell Physiol. 2020 Mar;235(3):2129-2138. doi: 10.1002/jcp.29117. Epub 2019 Aug 29. J Cell Physiol. 2020. PMID: 31468537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,062 results

Search Page